19 agosto 2022 – The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) approved a new manufacturing site for Vaxzevria. Vaxzevria is a vaccine for preventing Covid-19 in people aged 18 years and older.

For more information, see here.